acute rejection, 290
adhesion molecules, 67, 344
adoptive immunotherapy, 467
adrenaline, 247
adverse reactions, 247
ageing, 59
AIDS, 78, 91
airway hyperreactivity, 22
allergy, 1
allogeneic MLC, 350
ANCA, 283
animal model, 170
antibody, 91, 307, 326, 404
antibody engineering, 307
antibody response, 91
antigen-presenting cell, 370
antigens/peptides/epitopes, 404
anti-gliadin, 139
antineutrophil cytoplasmic autoantibodies, 252
anti-TNF antibodies, 38
APC, 414
apoptosis, 50, 350, 430
Aspergillus fumigatus, 370
atherosclerosis, 219
autoantibody, 378
autoimmune disease, 422, 461
autoimmunity, 1, 177, 404
B7, 97
BAL, 438
BALB/c, 170
BCG, 182
bone marrow transplantation, 193
α-crystallin, 177
C. neoformans, 91
C7 deficiency, 240
CD3, 307
CD4+ T cells, 260
CD14, 208
CD28/IL-12 synergy, 467
CD38, 384
CD40 ligand, 123
CD40, 22
CD57+ T cells, 438
CD64, 476
CD95, 430
cell activation, 11
cellular activation, 334
cellular differentiation, 334
Chemokine, 448
child, 360
clinical score, 38
coeliac, 139
coeliac disease, 422
complement, 156, 160, 326, 360
complement C5, 160
congenital rubella syndrome, 378
co-stimulatory molecules, 334
CpG oligonucleotides, 227
Crohn's disease, 108
cryoglobulinaemia, 275
cyclosporin-A/prednisone therapy, 233
cytokine, 11, 108, 334, 350
deficiency, 156
dendritic cells, 1, 50, 115, 233, 350
diabetes, 208, 378
E. coli O157, 360
EBV, 384
endothelial cells, 67, 219
endotoxin, 326
enterotoxin, 299
enzymed-linked immunosorbent assay, 360
eosinophil, 22
Fas, 430
Fcγ receptors, 240
formyl peptides, 267
function, 156
gene therapy, 193
genetic, 326
genetic diversity, 20
Glatirameracetate, 454
glomerulonephritis, 326
graft-versus-leukaemia, 467
haemolytic uraemic syndrome, 360
haemophagocytic lymphohistiocytosis, 448
HCV core protein, 275
heavy chain variable segment, 59
hepatitis C virus, 275
HIV-1, 78
HLA restriction, 260
HSV, 97
HTLV-1, 391, 397
HTLV-1 proviral load, 391
HTLV-I associated bronchopneumonopathy, 397
human, 59, 145, 208, 227
human β cells, 208
human B lymphocytes, 59
humoral response, 91
IBD, 38
IC, 200
IFN-γ, 97, 260, 476
Ig, 227
IgG antibodies, 364
IIF, 283
IL-5, 454
IL-10, 97
IL-12, 233, 414
IL-13, 454
IL-16, 290
IL-17, 344
immune complex(es), 275, 326
immune response, 20, 227
immune thrombocytopenia, 461
immunoglobulin, 219, 283, 422
immunoglobulin A, 283
immunoglobulin G, 422
immunoregulation, 145, 193
immunosuppression, 307, 485
immunotherapy, 318
infectious immunity-virus, 404
inflammation, 160, 177, 200, 252
inherited autoimmune disease, 193
innate immunity, 227, 252
innate immunity cytokine, 227
interleukin-10 knockout mice, 38
intestinal mucosa, 108
intravenous immunoglobulin, 247
invariant chain, 476
IP-10, 397, 448
knockout mice, 177
Langerhans cells, 370
latent autoimmune diabetes of adults, 139
Lck, 78
lectin, 370
leflunomide, 132
lens-associated uveitis, 177
leptin, 11
leptin receptor, 11
leucocytes, 267
liver disease, 283
LPS, 208
lung allograft, 290
lymphocyte, 11, 290
16-kDa M. tuberculosis antigen, 260
malaria, 145
mannan-binding lectin, 360
mannoproteins, 91
matrix metalloproteinases, 397
maturation, 115
MCP-1, 132
MDC, 132
membrane attack, 156
meningitis, 67
meningococcal infections, 240
MHC, 299
MHC class II, 44, 200, 476
MHC II, 44
MIG, 448
MIP-1α, 397
molecular diagnosis, 123
monoclonal antibody, 160, 318, 485
monocyte, 67, 200
Moroccan sephardic Jews, 240
mouse, 326
mucosal tolerance, 170
Multiple sclerosis, 454
necrosis, 50
neutrophils, 476
NK activity, 344
NOD mouse, 318
non-human primates, 182
obesity, 11
obliterative bronchiolitis, 290
oligosaccharides, 422
organ culture, 108
osteosarcoma, 344
oxidized LDL, 219
parasitic-protozoa, 145
PBMC, 11, 227
peptide, 310
placenta, 414
plasmodium, 414
platelets, 461
pneumococcal vaccination, 364
primary antibody deficiency, 247
prion, 310
quantitative flow cytometry, 384
receptor, 370
receptor–ligand interaction, 123
recombinant allergens, 170
rejection, 485
renal interstitium, 44
renal transplantation, 485
rheumatoid arthritis, 132
sarcoidosis, 438
serotype-specific assay, 364
serum sickness nephritis, 44
sICAM, 397
somatic hypermutation, 59
splenectomy, 461
Streptococcus suis, 67
Strongyloides stercoralis load, 391
strongyloidiasis, 391
subtotal, 156
superantigen, 299
susceptibility, 20
T cell, 1, 50, 115, 260, 350, 430, 461
T cell polarization, 115
T cell receptor, 260
T lymphocytes, 78, 334
T regulatory lymphocytes, 193
TAP defect, 252
TARC, 132
TcR, 299
Th1 cells, 438, 448
Th1 response, 11
Th1/Th2, 414
Th1/Th2 lymphocytes, 233
Th1/Th2 ratio, 22
therapy, 485
thyroidal, 139
TNF superfamily, 318
TNFα, 219
tolerance, 1
toxic shock, 299
transplantation, 1, 307
tuberculosis, 20, 182, 267
Type 1 diabetes, 318
type I latex allergy, 170
tyrosine kinases, 78
ulcerative colitis, 108
uveitis, 233
V(D)J recombination, 59
vaccination, 310
vaccines, 182
X-linked agammaglobulinaemia, 115
X-linked hyper-IgM syndrome, 123